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Abstract Four new 9,19-cycloartane triterpenoids, cimilactone E (1), cimilactone F (2), 20-O-(E)-butenoyl-23-epi-26-
deoxyactein (3), and 20,12b-O-diacetylcimiracemonol-3-O-b-D-xylopyranoside (4), together with four known constituents
(5–8) were isolated from the roots of Cimicifuga foetida. The new structures were elucidated by extensive spectroscopic
analysis. In addition, compounds 7 and 8 showed significant Wnt signaling pathway inhibitory activity, with IC50 values of
3.33 and 13.34 lM, respectively, using the luciferase reporter gene assay.
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1 Introduction
Wnt signaling pathway plays an important role in numer-
ous biological processes, including axis formation, cell fate
specification, cell polarity determination, and cell migra-
tion [1]. Pathologically, Wnt signaling pathway is fre-
quently aberrant in wide spectrum of malignancies, such as
colon cancer, liver cancer, leukemia, melanoma, pancreatic
cancer, and breast cancer [2]. Thus, screening inhibitors of
Wnt signaling pathway has been considered as effective
therapeutic strategies to combat cancer [3].
Traditionally, the roots of Cimicifuga foetida have been
used as a cooling and detoxifying remedy and officially
listed in the Chinese Pharmacopoeia [4]. The theory of
traditional Chinese medicine defines a tumor as a type of
toxin. Base on this theory, we hypothesized that chemical
constituents of Cimicifuga may have the effects against
cancer, which led us to uncover a series of 9,19-cycloartane
triterpenes. Many of them showed cytotoxic activity
against tumor cell lines, in which five compounds isolated
from C. yunnanensis induced apoptosis of MCF-7 cells via
p53-dependent mitochondrial pathway, recently [5–14].
However, there have been no reports about the Wnt sig-
naling pathway inhibitory activity of 9,19-cycloartane
triterpenes by far. Therefore, to further screen inhibitors
against Wnt signaling pathway from Cimicifuga spp., we
carried out a study on the roots of Cimicifuga foetida from
Yulong County of Yunnan province. Consequently, four
new compounds, cimilactone E (1), cimicilactone F (2),
2(E)-O-butenoyl-23-epi-26-deoxyactein (3), 20-O-acetyl-
cimirace-moside H (4), and four known compounds cimi-
cilactone A (5) [15], 12b-hydroxy-7(8)-en-cimigenol (6)
[16], cimicifoetiside B (7) [17], and 20-O-acetyl cimirace-
moside M (8) [18] (see Fig. 1) were isolated from C.
foetida. Furthermore, all compounds isolated were
evaluated for their inhibition of Wnt signaling pathway.
Among them, compounds 7 and 8 showed significant in-
hibitory activities (see Fig. 2), with IC50 values of 3.33 and
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13.34 lM, respectively. The present paper described the
isolation, structure elucidation, and biological activities of
aforementioned compounds.
2 Results and Discussion
Compound 1 was obtained as a white powder. The IR
spectrum showed absorptions for hydroxyl groups at
3438 cm-1 and carbonyl groups at 1735 cm-1, respec-
tively. Its molecular formula (C35H52O10) with ten degrees
of unsaturation was deduced from HREIMS (m/z 632.3533
[M]?; calcd. 632.3560). In 1H NMR spectrum (Table 1),
the characteristic cyclopropane methylene signals at dH
0.15 and 0.50 (each 1H, d, J = 4.3 Hz), one secondary
methyl signal at dH 0.98 (d, J = 6.4 Hz), four tertiary
methyl groups at dH 0.84–1.26 (each 3H, s), an anomeric
proton at dH 4.83 (1H, d, J = 8.0 Hz) and two acetyl
methyl groups at dH 2.16 and 2.18 (each 3H, s) were ob-
served. The 13C NMR and DEPT spectra of 1 exhibited 35
signals, of which 26 were attributed to the aglycon, five to a
pentose residue, and four to two acetyl groups. The
13C NMR and DEPT spectrum of the aglycon of 1 also
showed an ester carbonyl carbon at dC 174.2 and two
acetoxy carbonyl groups at dC 171.1 and 170.5. The
aforementioned data suggested that 1 was a 9,19-cycloar-
tane tetranortriterpene glycoside with three carbonyl
groups. The NMR spectroscopic data of 1 (Table 1) closely
resembled that of cimilactone A (5), except for the pres-
ence of an additional acetoxy group. In the HMBC spec-
trum (Fig. 3), a correlation was observed between the
proton at dH 4.87 (1H, d, J = 8.0 Hz, H-10) and the me-
thine carbon at dC 88.8 (C-3), suggesting that the sugar
moiety was located at C-3. In 1H-1H COSY spectrum, the
Fig. 1 Structures of compounds 1–8
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Table 1 NMR data of compounds 1 and 2 (d in ppm and J in Hz)
Position 1a 2a 3a 4a
dC dH dC dH dC dH dC dH
1 32.4 t 1.06 m
1.45 m
32.2 t 1.06 m
1.46 m
32.2 t 1.07 m
1.46 m
32.2 t 1.06 m
1.44 m
2 30.2 t 1.80 m
2.19 m
30.2 t 1.82 m
2.21 m
30.2 t 1.80 m
2.20 m
30.2 t 1.78 m
2.19 m
3 88.6 d 3.34 dd (4.4, 11.5) 88.7 d 3.37 dd (4.2, 11.4) 88.7 d 3.34 dd (4.2, 11.6) 88.7 d 3.34 dd (4.2, 11.4)
4 41.3 s 41.4 s 41.3 s 41.3 s
5 47.2 d 1.22 dd (4.3, 11.2) 47.2 d 1.22 m 47.2 d 1.18 m 47.3 d 1.22 m
6 20.8 s 0.69 m
1.47 m
20.8 s 0.67 m
1.46 m
20.4 t 0.56 m
1.37 m
20.4 t 0.68 m
1.44 m
7 26.1 t 0.91 m
1.22 m
26.1 t 0.90 m
1.22 m
26.1 t 0.87 m
1.16 m
26.2 t 0.90 m
1.24 m
8 46.5 d 1.57 dd (5.0, 12.1) 46.5 d 1.55 dd (4.8, 12.0) 46.2 d 1.53 dd (5.4, 12.0) 46.2 d 1.54 dd (5.4, 9.4)
9 20.5 s 20.5 s 20.7 s 20.9 s
10 27.2 s 27.2 s 26.9 s 26.9 s
11 36.8 t 1.14 dd (3.6, 16.2)
2.71 dd (8.9, 16.2)
36.8 t 1.13 m
2.71 dd (9.0, 16.2)
37.1 t 1.16 m
2.71 m
37.2 t 1.14 m
2.73 dd(9.0, 16.2)
12 77.0 d 5.07 dd (3.6, 8.9) 77.0 d 5.06 dd (3.6, 9.0) 77.4 d 5.09 m 77.4 d 5.15 m
13 48.6 s 48.6 s 49.2 s 49.8 s
14 49.0 s 49.0 s 48.1 s 48.5 s
15 44.2 t 1.84 dd (5.6, 13.6)
2.01 dd (8.0, 13.6)
44.2 t 1.83 m
1.99bdd (8.4, 13.8)
44.6 t 1.76 m
1.88 dd (7.8, 12.6)
43.5 t 1.76 dd (8.4, 11.4)
1.94 dd (7.8, 12.0)
16 80.8 d 4.82 m 80.8 d 4.81 m 74.9 d 4.24 m 72.5 d 5.03 dd (7.8, 16.2)
17 54.1 d 2.15 m 54.0 d 2.15 m 56.6 d 1.77 m 52.9 d 1.82 dd (10.2, 19.2)
18 13.7 q 1.26 s 13.7 q 1.24 s 14.7 q 1.47 s 14.2 q 1.37 s
19 30.1 0.15 d (4.3)
0.50 d (4.3)
30.1 t 0.15 d (4.2)
0.48 d (4.2)
29.9 t 0.14 d (4.2)
0.44 d (4.2)
30.1 t 0.15 d (3.6)
0.46 d (3.6)
20 27.1 d 2.01 m 27.1 d 2.05 m 23.7 q 2.24 m 34.9 d 2.29 m
21 22.3 q 0.98 d (6.4) 22.3 q 0.97 d (6.0) 21.7 q 1.02 d (6.6) 18.9 q 1.35 d (6.0)
22 39.1 t 2.28 m
2.49 dd (3.5, 14.6)
39.0 t 2.28 m
2.48 dd (3.6, 15.0)
37.9 t 1.44 m
1.59 dd (3.0, 13.8)
87.1 d 3.91 d (10.8)
23 174.2 s 174.2 s 106.3 s 106.0 s
24 62.6 d 3.68 s 83.7 d 4.24 s
25 62.9 s 83.7 s
26 68.5 t 3.63 d (10.2)
4.06 d (10.2)
28.2 q 1.79 s
27 13.9 t 1.41 s 25.3 q 1.72 s
28 20.0 q 0.84 s 19.9 q 0.83 s 20.1 q 0.83 s 20.1 q 0.85 s
29 25.8 q 1.10 s 25.8 q 1.12 s 25.8 q 1.10 s 25.8 q 1.10 s
30 15.5 q 0.94 s 15.5 q 0.94 s 15.5 q 0.91 s 15.5 q 0.92 s
3-Xyl
10 105.0 d 4.83 d (8.0) 105.2 d 4.89 d (7.8) 105.2 d 4.88 d (7.8) 105.0 d 4.82 d (7.8)
20 76.1 d 5.58 dd (8.0, 9.0) 75.8 d 5.68 dd (7.9, 9.0) 75.8 d 5.67 dd (7.8, 10.2) 76.1 d 5.58 t (9.0)
30 76.6 d 4.20 m 76.8 d 4.26 m 76.8 d 4.23 m 76.6 d 4.19 m
40 71.7 d 4.23 m 71.8 d 4.26 m 71.7 d 4.25 m 71.7 d 4.22 m
50 67.5 t 3.71 dd (9.9, 10.8)
4.33 dd (5.0, 10.8)
67.6 t 3.74 m
4.35 dd (4.2, 11.4)
67.6 t 3.74 t (10.8)
4.35 dd (4.2, 10.8)
67.5 t 3.70 t (10.8)
4.32 dd (4.2, 10.8)
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correlations of a downfield resonance at dH 5.58 (1H, dd,
J = 8.0 and 9.0 Hz, H-20) with H-30 (dH 4.20, m) and H-10
(dH 4.83, d, J = 8.0 Hz), together with the HMBC corre-
lations from the proton resonance (H-20) to a carbonyl
group (dC 170.5, s) located the acetoxy group at C-20. The
sugar obtained after acid hydrolysis was identified as D-
xylose by comparing its TLC and specific rotation with a
standard. The relative configurations of H-3, H-5, H-12,
H-16, and H-17 were established as in the a-orientation on
the basis of the ROESY correlations of H-10/H-3; H-3/H-5;
H-12/H-17; H-16/H-17 and H-17/Me-18 (Fig. 3). There-
fore, the structure of 1 was determined to be (3b,12b,16b)-
12,20–diacetoxy-3-hydroxy-24,25,26,27-tetranor-cycloartan-
23,16-olide 3-O-b-D-xylopyranside (1), named cimilactone E.
Compound 2 was obtained as a white powder. The IR
spectrum showed absorptions for hydroxyl (3442 cm-1),
carbonyl group (1732 cm-1), and double bond
(1632 cm-1), respectively. The HREIMS spectrum gave an
[M]? ion peak at m/z 658.3713 (calcd 658.3717), consistent
with the molecular formula C37H54O10, requiring eleven
rings or sites of unsaturation. The NMR data of 2 was
similar to cimilactone E (1), except for the resonances of
the sugar moiety. The 13C NMR spectrum revealed carbons
assignable to a 2-butenoyl moiety at dC 165.8 (s), 123.6 (d),
144.8 (d). Besides, the correlation from the proton reso-
nance (dH 5.68, dd, J = 7.9 and 9.0 Hz, H-20) to the car-
bonyl group (dC 166.2, s, C-100) in the HMBC spectrum
located the 2-butenoyl group at C-20, which was further
confirmed by the 1H-1H COSY correlations of the proton at
dH 5.68 (H-20) with H-10 and H-30. In addition, the coupling
constant (J = 15.6 Hz) of the two olefinic protons at dH
6.12 (H-200) and dH 7.14 (H-300) confirmed the E-geometry
of a double bond in the 2-butenoyl moiety. The sugar ob-
tained after acid hydrolysis was confirmed as D-xylose by
comparing its TLC and specific rotation with a standard.
The relative configurations of H-3, H-5, H-12, H-16, and
Fig. 2 Inhibition of luciferase activity
Table 1 continued
Position 1a 2a 3a 4a
dC dH dC dH dC dH dC dH
12-COCH3 171.1 s 171.1 s 171.1 s 171.1 s
12-COCH3 21.9 q 2.18 s 21.9 q 2.16 s 22.1 q 2.15 s 22.1 q 2.10 s
20-COCH3 170.5 s 170.5 s
20-COCH3 21.7 q 2.16 s 21.7 q 2.17 s
20-butenoyl
100 166.2 s 166.2 s
200 123.6 d 6.12 d (15.6) 123.6 d 6.11 dd (1.6, 15.5)
300 145.4 d 7.14 m 145.4 d 7.12 m
400 18.2 q 1.68 d (6.6) 18.2 q 16.7 d (6.6)
a Measured in pyridine-d5
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H-17 were proposed as a-orientation, respectively, by the
same way as that of 1. Therefore, the structure of 2 was
identified as (3b,12b,16b)-12-acetoxy-3-hydroxy-24,25,26,27-
tetranor-cycloartan-23,16-olide-3-O-{20-O-(E)-200-butenoyl}-b-
D-xylopyran-side (2), named cimilactone F.
Compound 3, was obtained as white powder, which
gave an [M]? ion at m/z 728.4120 [M]? (calcd 728.4120)
in HREIMS, consistent with the molecular formula of
C41H60O11. The IR spectra showed absorption bands for
hydroxyl groups at 3442 cm-1, carbonyl groups at
1730 cm-1 and double bond at 1632 cm-1, respectively.
Typical proton signals of a cyclopropane methylene group
(dH 0.14 and 0.44, each 1H, d, J = 4.3 Hz); five tertiary
methyl groups (dH 0.83–1.47, each 3H, s); two secondary
methyl group [(dH 1.02 (3H, d, J = 6.0 Hz) and 1.67 (3H,
d, J = 6.6 Hz)]; one acetyl methyl group (dH 2.15, 3H, s);
one 2(E)-butenoyl group [dH 6.11 (1H, dd, J = 1.6 and
15.5 Hz), 7.12 (m) and 16.7 (3H, d, J = 6.6 Hz)], and an
anomeric proton (dH 4.88, 1H, d, J = 7.8 Hz) were ob-
served in the 1H NMR spectrum (Table 1). The 13C NMR
and DEPT spectrum (Table 1) of 3 exhibited 41 signals, of
which 30 were attributed to the aglycon, five to a pentose
residue, two to an acetyl group, and four to an 2-butenoyl
group. Additionally, the aglycon of 3 also showed a
hemiketal moiety at dC 74.9 (d), 106.3 (s) and 68.5 (t), and
an epoxyethane signals at dC 62.6 (d) and 62.9 (s), which
indicated that the aglycon of 3 was similar with 23-epi-
deoxyacteol. A comparison of the spectroscopic data of 3
with those of 23-epi-26-deoxyactein showed that 3 closely
resembles of it except for the presence of another tetra-
carbon unit (2-butenoyl group) [19]. Additionally, the E-
geometry of a double bond in the 2-butenoyl was con-
firmed in the same way with that of 2. In 1H-1H COSY
spectrum, the correlations of a resonance at dH 7.12 (m,
H-300) with H-200 (dH 6.11, dd, J = 1.6 and 15.6 Hz) and
H-400 (dH 1.67, d, J = 6.6 Hz), together with the HMBC
correlation from the proton resonance (dH 5.67, dd, J = 7.8
and 10.2 Hz, H-20) to a carbonyl group (dC 166.2, s) lo-
cated the 2(E)-butenoyl group at C-20. Thus, 3 was char-
acterized as 20-O-2(E)-butenoyl-23-epi-26-deoxyactein (3).
Compound 4 was obtained as a white powder. The IR
spectrum showed absorptions for hydroxyl (3439 cm-1),
carbonyl groups (1730 cm-1), respectively. Its molecular
formula (C39H60O12) with ten degrees of unsaturation was
deduced from the analyses of 13C NMR and HREIMS data
(m/z 720.4078 [M]?; calcd. 720.4085). In 1H NMR spec-
trum (Table 1), the signals due to a cyclopropane methy-
lene group (dH 0.15 and 0.46, each 1H, d, J = 3.6 Hz); six
tertiary methyl groups (dH 0.85–1.79, each 3H, s); one
secondary methyl group (dH 1.35, 3H, d, J = 6.0 Hz); two
acetyl methyl group (dH 2.17 and 2.10, each 3H, s); and an
anomeric proton (dH 4.82, 1H, d, J = 7.8 Hz) were ob-
served. The 13C NMR and DEPT spectrum (Table 1) of 4
exhibited 39 signals, of which 30 were attributed to the
aglycon, five to a pentose residue, and four to two acetyl
groups. All above showed 4 was similar to cimiracemoside
H, except for the presence of an additional acetoxy group.
In 1H-1H COSY spectrum, the correlations of a resonance
at dH 4.19 (m, H-30) with H-20 (dH 5.58, t, J = 9.0 Hz) and
H-40 (dH 4.22, m), together with the HMBC correlation
from a carbonyl group (dC 170.5, 3H, s) to the proton
resonance (dH 5.58, H-20) located the acetoxy group at
C-20. The ROESY correlations of H-17/H-22 and Me-21/
H-24 proved H-22 in the a-orientation and H-24 as R con-
figuration. Therefore, 4 was characterized as (3b,12b,
16b,20S,22R,23S,24R)-16:23; 22:25-diepoxy-12,20-diace-
toxy-3,23,24-trihydroxy-9, 19-cyclocanostane-3-O-b-D-xy-
lopyranoside (4), named 20-O-acetyl cimiracemoside H.
As noted in the introduction, the roots of C. foetida have
been used as cooling and detoxification agents by Chinese
people since ancient time. Previous reports have shown that
many pure 9,19 cycloartane triterpenoids isolated from this
species exhibited cytotoxic activity against 11 tumor cell
lines (including HepG2, MDA-MB-A231, HL-60, SMMC-
7721, A549, SK-BR-3, PANC-1, K562, U933, HEG-2, and
SGC-7091) in vitro, respectively [5–7, 17, 20, 21]. But
there is no report on inhibition of Wnt signaling pathway.
The pure components isolated in the present paper were
screened against Wnt signaling pathway using the lu-
ciferase reporter gene assay. The known compounds 7 and
8 showed notable activity with the IC50 values of 3.33 and
13.34 lM, respectively. To the best of our knowledge, this
is the first time to report the inhibitory activity against Wnt
signaling pathway of 9,19-cycloartane triterpenes. These
data suggested that some chemical constituents from C.
foetida might be valuable to against tumorigenesis through
inhibition to Wnt signaling pathway.
3 Experiments Section
3.1 General Experimental Procedures
UV spectra were recorded in MeOH on a shimadizu UV-
210A spectrometer. IR spectra were recorded on Shimadzu
IR-450 spectrometer with KBr disc. Optical rotations were
measured a Horiba SEAP-300 polarimeter. 1H NMR and
13C NMR spectra were recorded using a Bruker AM-600
spectrometer with TMS as internal standard, operating at
600 and 150 MHz, respectively. All compounds were
measured in solvents pyridine-d5. ESIMS and HRESIMS
were carried out on a Waters Autospec Premier-P776
spectrometer. TLC analysis was performed on silica gel
GF254 plate (Qingdao Marine Chemical, Inc.). Lichroprep
RP-18 (40–63 lm, Merck) and silica gel (200–300 mesh)
was used for column chromatography. Semipreparative
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HPLC was carried out on an Agilent 1260 liquid chro-
matograph with a ZORBAX SB C-18 column (9.4 9
250 mm,5 lm,) and a ZORBAX XDB C-18 column
(9.4 9 250 mm, 5 lm).
3.2 Plant Materials
The roots of C. foetida (82 kg) were collected from Yulong
County of Yunnan province of China in September 2010
and authenticated by Prof. Shen-Ji Pei of Kunming Institute
of Botany, where a voucher specimen (KUN No.
20100906) is deposited.
3.3 Extraction and Isolation
The air-dried roots of C. foetida (82 kg) were crushed with a
blender and refluxed with 95 % MeOH for three times (5 h,
each). The residue yield by removal of the solvent was dis-
solved in water to form a suspension. The aqueous suspen-
sion was successively partitioned with EtOAc and n-BuOH.
The EtOAc (5.6 kg) fraction was absorbed on 12 kg silica
gel and chromatographed on a prepacked (120 kg) silica gel
column, eluting stepwise with CHCl3-MeOH (CHCl3,
100:1, 50:1, 20:1, 5:1) to give five fractions (I–V). Fr.IV
(350 g) was subjected to silica gel chromatograph eluted
with CHCl3-acetone (10: 1) to give five sub-fractions (Fr.IV.
1–5). Fr.IV.4 (0.5 g) was chromatographed repeatedly over
HPLC (SB C-18 column, CH3CN-H2O, 7:3) to obtain
compound 7 (5 mg) successively. Fr.IV.5 (5 g) was applied
repeatedly to CC over RP-18 gel (60, 70, 80 and 90 %
MeOH-H2O) to give fractions IV.5.1–4. Fr.IV.5.2 (60 mg)
afforded compound 6 (5 mg), after repeated elution with a
CHCl3-acetone (5:1, 3:2) system over silica gel CC and a
CH3CN-H2O (65 %) over HPLC (SB C-18 column).
Fr.IV.5.3 (450 mg) was separated by column chromatograph
eluted with CHCl3-acetone (3:1), and by HPLC (SB C-18
column) with CH3CN/H2O (45 %) to obtain compounds 1
(10 mg), 4 (2.2 mg) and 5 (3 mg), respectively. Fr.IV.5. 4
(380 mg) was also separated by column chromatograph
eluted with CHCl3-acetone (3:1), then HPLC (XDB C-18
column) with CH3CN-H2O (65 %) to yield compounds 2
(1.6 mg), 3 (1.8 mg) and 8 (5 mg).
Compound 1: white powder (MeOH); ½a20D :-41.67 (c 0.24,
MeOH); UV (MeOH) kmax (log e): 209 (2.32) nm; IR (KBr)
vmax: 3438 (OH), 2964, 1735 (C=O), 1631(C=C), 1442, 1375,
1242, 1032, 982 cm-1; positive HRESIMS m/z 632.3533
[M]?, (C35H52O10, calcd. 632.3560),
1H and 13C NMR data,
see Table 1.
Compound 2: white powder (MeOH); ½a20D : -90.67
(c 0.06, MeOH); UV (MeOH) kmax (log e): 206 (4.29) nm;
IR (KBr) vmax: 3442 (OH), 2963, 2936, 1732 (C=O),
1655(C=C), 1444, 1365, 1245, 1184, 1072, 984 cm-1;
positive HRESIMS m/z 658.3713 [M]?, (C37H54O10, calcd.
658.3717), 1H and 13C NMR data, see Table 1.
Compound 3: white powder (MeOH); ½a20D : -49.18
(c 0.18, MeOH); UV (MeOH) kmax (log e): 206 (4.14) nm;
IR (KBr) vmax: 3441 (OH), 2932, 1730 (C=O), 1651(C=C),
1443, 1365, 1250, 1184, 1072, 1032, 982 cm-1; positive
HRESIMS m/z 728.4120 [M]?, (C41H60O11, calcd.
728.4136), 1H and 13C NMR data, see Table 1.
Compound 4: white powder (MeOH); ½a20D : -19.67
(c 0.13, MeOH); UV (MeOH) kmax (log e): 201 (3.58) nm;
IR (KBr) vmax: 3439 (OH), 2939, 1735 (C=O), 1632(C=C),
1462, 1377, 1244, 1159, 1047, 981, 602–576 cm-1; posi-
tive HREIMS m/z 720.4078 [M]?, (C39H60O12, calcd.
720.4085), 1H and 13C NMR data, see Table 1.
The known compounds, cimilactone A (5), 12b-hydroxy-
7(8)-en-cimigenol (6), cmicifoetiside B (7) and 20-O-acetyl
cimiracemoside M (8) were identified by comparing their
physical and spectroscopic data with reported data.
Fig. 3 Key 1H-1H COSY, HMBC and ROESY correlations of compound 1
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3.4 Acidic Hydrolysis of 1–4
A solution of each new compound (1 mg) in 0.5 N HCl
(3 ml) was refluxed for 4 h. The reaction mixture was di-
luted in 10 mL water and extracted with chloroform. After
separating the organic layer, the aqueous phase was neu-
tralized with Ag2CO3 to obtain some white precipitate. The
precipitate residue was dissolved in pyridine and analyzed
by TLC in n-BuOH-acetone-H2O (4:3:1, v/v), which had
the same Rf value with D-(?)-xylose [22].
3.5 Luciferase Activity
The Wnt signaling inhibitory activity of the eight 9,
19-cycloartane triterpenes (1–8) using the luciferase re-
porter gene assay as previously described [2]. Briefly,
HEK293W cells were seeded in 96 well plate, and the
luciferase activities were measured after incubation with
the triterpenes for 24 h, using the Dual-Lucy Assay Kit
(Promega) according to the manufacturer’s instructions.
Acknowledgments This project was supported by Program for
National Natural Science Foundation of China (Nos. U1132604 and
81302670), The Major Deployment Program of the CAS (No. KSZD-
EW-Z-004-01), and Foundation of State Key Laboratory of Phyto-
chemistry and Plant Resources in West China (P2008-ZZ05). Authors
also were particularly grateful to Research Group of Prof. Yan Li for
bioassay tests.
Conflict of Interest All authors declare no conflict of interest.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
References
1. K.M. Cadigan, R. Nusse, Genes Dev. 11, 3286–3305 (1997)
2. X.Y. Li, Y.Y. Wang, C.G. Yuan, X.J. Hao, Y. Li, Nat. Prod.
Bioprospect. 3, 24–28 (2013)
3. A. Gregorieff, H. Clevers, Genes Dev. 2005(19), 877–890 (2005)
4. Pharmacopoeia Commission of the People’s Republic of China,
The Pharmacopoeia of Chinese People’s Republic (The Chemical
Industry Publishing House, Beijing, 2010), pp. 68–69
5. Y. Nian, M.X. Zhang, Y. Li, Y.Y. Wang, J.C. Chen, L. Lu, L.
Zhou, M.H. Qiu, Phytochemistry 72, 1473–1481 (2011)
6. Y. Nian, H.Y. Wang, J. Su, L. Zhou, M.H. Qiu, Fitoterapia 83,
293–297 (2012)
7. L. Lu, J.C. Chen, Y. Li, C. Qing, Y.Y. Wang, Y. Nian, M.H. Qiu,
Chem. Pharm. Bull. 60, 571–577 (2012)
8. D.S. Li, Y. Nian, Y. Sun, M.H. Qiu, Helv. Chim. Acta 94,
632–638 (2011)
9. L.R. Sun, J. Yan, L. Lu, S.J. Pei, Z.R. Li, L. Zhou, X.M. Zhang,
M.H. Qiu, Helv. Chim. Acta 90, 1313–1318 (2007)
10. L. Lu, J.C. Chen, H.J. Song, Y. Li, Y. Nian, M.H. Qiu, Chem.
Pharm. Bull. 58, 729–733 (2010)
11. D.F. Zhu, Y. Nian, H.Y. Wang, Z.R. Zhang, Y.B. Song, R.T. Li,
M.H. Qiu, J. Nat. Med. 12, 0294–0296 (2014)
12. H.Y. Wang, Y. Nian, C.Y. Ma, J.Q. Liu, Y.B. Song, L. Zhou,
M.H. Qiu, Chin. J. Chem. 30, 1265–1268 (2012)
13. Y. Nian, H.Y. Wang, L. Zhou, J. Su, Y. Li, M.H. Qiu, Planta
Med. 79, 60–69 (2013)
14. Y. Nian, H. Zhu, W.R. Tang, Y. Luo, J. Du, M.H. Qiu, J. Nat.
Prod. 76, 896–902 (2013)
15. Y. Liu, D. Chen, J. Si, G. Tu, D. An, J. Nat. Prod. 65, 1486–1488
(2002)
16. Y. Nian, H.Y. Wang, L. Zhou, J. Su, Y. Li, M.H. Qiu, Planta
Med. 78, 1–10 (2012)
17. L.R. Sun, C. Qing, Y.L. Zhang, S.Y. Jia, Z.R. Li, S.J. Pei, M.H.
Qiu, L.G. Michael, X.Q. Samuel, Beilstein J. Organ. 3(3) (2007)
18. Y.S. Fan, W. Jia, A.H. Zhao, J. Tang, H.Q. Duan, Chin. Chem.
Lett. 17, 1477–1480 (2006)
19. S.N. Chen, W. Li, D.S. Fabricant, B.D. Santarsiero, A. Mesecar,
J.F. Fitzloff, H.H.S. Fong, N.R. Farnsworth, J. Nat. Prod. 65,
601–605 (2002)
20. Z. Tian, R.L. Pan, J.Y. Si, P.G. Xiao, Fitoterapia 77, 39–42
(2006)
21. J.Y. Chen, P.L. Li, X.L. Tang, X.L. Tang, S.J. Wang, Y.T. Jiang,
L. Shen, B.M. Xu, Y.L. Shao, G.Q. Li, J. Nat. Prod. 77,
1997–2005 (2014)
22. Y. Shao, A. Harris, M. Wang, H. Zhang, A.C. Geoffrey, M.
Bowman, E. Lemmo, J. Nat. Prod. 63, 905–910 (2000)
Cycloartane Glycosides from the Roots of C. foetida 67
123
